Latest Articles and Analysis

For the first time, a finite course of therapy has produced a functional cure for chronic hepatitis B in large-scale phase 3 trials, but the communities carrying the heaviest burden of this disease are also the least likely to be screened, diagnosed, or insured. Whether this milestone translates into population-level progress is a policy question, not a scientific one.

A proposed OMB rule would let political appointees veto or cancel federal research grants, dismantling the peer-review system and targeting the disparate-impact analysis that maps where HIV concentrates and why. For people living with HIV, that research is the foundation of Ending the HIV Epidemic. The comment period closes July 13.

On April 24, 2026, a nurse in Ituri Province in the Democratic Republic of the Congo (DRC) developed a fever. She died three days later. Her samples were tested locally and returned negative, because...

The Centers for Disease Control and Prevention (CDC) released its National HIV Prevention and Care Objectives: 2026 Update on May 18, 2026, presenting the most recent national picture of the U.S. HIV...

For a long time, I thought advocacy meant surviving the next appointment. I thought it meant learning how to explain my pain better, how to prepare for another referral visit, how to justify why I...

States are rationing HIV medications through prior auth and formulary cuts to solve ADAP budget crises — a strategy that costs more, drives resistance, and concentrates harm on the most vulnerable.

Rising employer premiums averaging 9.5% erode wages, forcing workers to delay care.

Historical redlining policies correlate with current geographic disparities in HIV treatment access and care quality.

Elimination of health equity research funding undermines evidence base for addressing healthcare disparities and structural inequalities.

Data gaps in HIV surveillance for transgender people and policy implications.

Elevated HCV prevalence among HIV-positive MSM and co-infection management implications.

How payor cost-containment strategies drive health disparities and limit care access.

Transgender communities face elevated HIV risk; stigma and discrimination undermine prevention.

Congenital syphilis cases tripled since 2017; integrated response including testing and education needed.

Payer denial of PrEP disproportionately fails Black women and marginalized communities.

Q4 2023 Watch: Bipartisan PEPFAR reauthorization push; ADAP coverage and Medicaid updates tracked.

OIG report: 27% of Medicaid HIV enrollees lack evidence of critical services; state disparities exposed.

Opioid settlement funds risk misallocation; MAT gaps for minors and drug court issues identified.

Q3 2023 Watch: HIV disparities coverage; debt ceiling crisis impacts; Medicaid disenrollment trends tracked.

CDC report: HCV persists despite decade-old cure due to payer barriers and screening failures.